Ophthalmology · St Petersburg, FL
NPI
1003816018
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
5800 49th St N, S-109
St Petersburg, FL, 33709
Phone (727) 522-1115
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
64,505 services
Medicare patients, 2024
916
Average age 78
Drug cost, 2024
$227K
455 prescriptions
Company payments, 2024
$302
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Martin E Orlick was code J2403 (chloroprocaine hcl ophthalmic, 3% gel, 1 mg), 29,600 times for 13 patients. In total Martin E Orlick billed 64,505 services in 41 codes, and Medicare paid $1.6M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2403 Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | Office | 29,600 | 13 | $0.52 | $15K |
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 28,081 | 113 | $27.56 | $774K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,536 | 851 | $27.83 | $43K |
| 99214 Office E&M - Established | Office | 946 | 782 | $85.29 | $81K |
| 67028 Intravitreal Injection | Office | 776 | 199 | $90.12 | $70K |
| 99213 Office E&M - Established | Office | 686 | 294 | $64.42 | $44K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 456 | 15 | $256.60 | $117K |
| J0178 Injection, aflibercept, 1 mg | Office | 438 | 58 | $653.16 | $286K |
| 92250 Angiography | Office | 432 | 292 | $26.33 | $11K |
| J2778 Injection, ranibizumab, 0.1 mg | Office | 355 | 21 | $126.74 | $45K |
| 92235 Angiography | Office | 53 | 53 | $107.74 | $5,710 |
| 99212 Office E&M - Established | Office | 50 | 46 | $40.95 | $2,047 |
| 99204 Office E&M - New | Office | 47 | 47 | $106.55 | $5,008 |
| 92201 Ophthalmological E&M | Office | 39 | 35 | $17.97 | $701 |
| 92083 Vision, Hearing, and Speech Services | Office | 31 | 30 | $40.76 | $1,264 |
By year: 2022 $2.1M for 15,414 services; 2023 $2.3M for 57,771 services; 2024 $1.6M for 64,505 services.
Medicare prescription drug claims, 2024
In 2024, the drug Martin E Orlick prescribed most often to Medicare patients was Timolol Maleate, with 78 prescriptions and refills. In total Martin E Orlick wrote 455 Medicare prescriptions that cost $227K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Timolol Maleate Generic | 78 | 123 | 23 | $765 |
| Latanoprost Generic | 73 | 131 | 21 | $880 |
| Vabysmo Faricimab-Svoa | 46 | 69 | 13 | $128K |
| Prednisolone Acetate Generic | 45 | 68 | 33 | $2,618 |
| Ketorolac Tromethamine Generic | 43 | 49 | 35 | $1,759 |
| Dorzolamide Hcl Generic | 25 | 55 | Under 11 | $591 |
| Brimonidine Tartrate Generic | 20 | 35 | Under 11 | $200 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 19 | 41 | Under 11 | $104 |
| Eylea Aflibercept | 16 | 35 | Under 11 | $37K |
| Lumigan Bimatoprost | 12 | 17 | Under 11 | $4,664 |
| Lucentis Ranibizumab | 11 | 23 | Under 11 | $27K |
Brand drugs: 208 claims; generic drugs: 247 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Martin E Orlick $302 ($302 in general payments such as food, travel and fees) from 5 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $155.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.